Deseret Mutual Benefit Administrators Has $609,000 Stock Holdings in CVS Health Co. (NYSE:CVS)

Deseret Mutual Benefit Administrators boosted its holdings in CVS Health Co. (NYSE:CVS) by 5.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 13,563 shares of the pharmacy operator’s stock after purchasing an additional 741 shares during the quarter. Deseret Mutual Benefit Administrators’ holdings in CVS Health were worth $609,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in CVS. AMF Tjanstepension AB grew its holdings in CVS Health by 124.1% in the third quarter. AMF Tjanstepension AB now owns 61,744 shares of the pharmacy operator’s stock worth $3,882,000 after purchasing an additional 34,198 shares during the period. McAdam LLC acquired a new stake in shares of CVS Health in the 3rd quarter valued at about $274,000. International Assets Investment Management LLC increased its position in CVS Health by 8,947.4% in the 3rd quarter. International Assets Investment Management LLC now owns 1,145,849 shares of the pharmacy operator’s stock valued at $72,051,000 after buying an additional 1,133,184 shares in the last quarter. DT Investment Partners LLC raised its stake in CVS Health by 7.8% during the 3rd quarter. DT Investment Partners LLC now owns 2,777 shares of the pharmacy operator’s stock worth $175,000 after buying an additional 202 shares during the period. Finally, Tectonic Advisors LLC boosted its holdings in CVS Health by 18.2% in the third quarter. Tectonic Advisors LLC now owns 12,878 shares of the pharmacy operator’s stock worth $810,000 after acquiring an additional 1,985 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.

CVS Health Price Performance

CVS opened at $63.42 on Friday. CVS Health Co. has a fifty-two week low of $43.56 and a fifty-two week high of $80.75. The firm has a 50-day moving average of $52.39 and a 200 day moving average of $56.23. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The firm has a market cap of $79.95 billion, a P/E ratio of 17.33, a PEG ratio of 0.99 and a beta of 0.61.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, research analysts expect that CVS Health Co. will post 5.9 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were given a dividend of $0.665 per share. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.19%. CVS Health’s dividend payout ratio is presently 72.68%.

Insider Transactions at CVS Health

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 18th. The shares were bought at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the purchase, the director now owns 39,356 shares of the company’s stock, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.24% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Barclays upped their target price on CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a research report on Thursday, February 13th. Truist Financial upped their price objective on shares of CVS Health from $60.00 to $76.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. Royal Bank of Canada reduced their price objective on shares of CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a report on Friday, November 15th. StockNews.com upgraded shares of CVS Health from a “sell” rating to a “hold” rating in a report on Thursday, February 13th. Finally, Leerink Partners upgraded CVS Health from a “market perform” rating to an “outperform” rating and lifted their price target for the company from $55.00 to $75.00 in a research note on Thursday, February 13th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. According to MarketBeat, CVS Health currently has a consensus rating of “Moderate Buy” and an average price target of $70.00.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.